Analyst Ratings for Edwards Lifesciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 12 analysts have published their opinion on Edwards Lifesciences (NYSE:EW) stock. The analysts have an average price target of $101.5 versus the current price of Edwards Lifesciences at $77.725, implying an upside. The current average has increased by 0.82% from the previous average price target of $100.67.
August 17, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Edwards Lifesciences (NYSE:EW) with an average price target of $101.5, implying an upside.
The bullish outlook from analysts indicates a positive sentiment towards Edwards Lifesciences. The average price target of $101.5, which is higher than the current price, suggests that the stock has potential for growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100